Blue Earth Diagnostics and PETNET Solutions Inc, A Siemens Healthineers Company, Announce U.S. Commercial Availability of POSLUMA (Flotufolastat F 18) Injection for PET Imaging of Prostate Cancer

POSLUMA is now commercially available in multiple U.S. radiopharmacies, with nationwide availability by end of June 2023 

Related Keywords

Chicago ,Illinois ,United States ,Davide Gauden ,Barry Scott ,Siemens Healthineers Company ,Society Of Nuclear Medicine ,Drug Administration On ,Blue Earth Diagnostics Ltd ,Solutions Inc ,Blue Earth Diagnostics ,Prostate Specific Membrane Antigen ,Drug Administration ,New Drug Application ,Chief Executive Officer ,Medicare Advantage Plans ,Earth Diagnostics ,Nuclear Medicine ,Molecular Imaging ,Annual Meeting ,